The survey is put out every two years and is used to help guide the city’s annual budget decisions for the next two fiscal years.

Sarah Boyce, President and CEO of Avidity Biosciences, Inc. (NASDAQ:RNA), recently sold shares of the company's common stock valued at approximately $297,291. The transactions, disclosed in a recent ...